Clinical Trial

The Direct Oral Anticoagulation Versus Vitamin K Antagonist After Cardiac Surgery Trial

Study acronym: DANCE
Recruiting Phase 3
View on ClinicalTrials.gov →
Summary
The DANCE Trial is a multi-centre, randomized controlled trial comparing the safety of direct oral anticoagulants (DOAC) versus vitamin K antagonists (VKA) in the early period (30 days) after cardiac surgery in patients with atrial fibrillation requiring oral anticoagulation.
Protocol Amendment History 8 amendments
This ClinicalTrials.gov record has been amended 8 times since 2020-02-24; most recent amendment 2025-09-23.
Status change: Not Yet Recruiting → Recruiting 2021-08-09
Trial Details
NCT Number NCT04284839
Lead Sponsor Population Health Research Institute
Collaborators: Hamilton Health Sciences Corporation
Conditions Bleeding Post Cardiac Surgery, Indication for Anticoagulation
Enrollment 3,500 participants
Start Date 2021-07-18
Primary Completion 2027-06 (estimated)
Study Completion 2027-06 (estimated)
Updated on ClinicalTrials.gov 2025-09-29